Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study

Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study

Abstract Background Cold urticaria (ColdU) is characterized by pruritic wheals following exposure of the skin to cold. Many patients show insufficient response to antihistamines, the first line treatment. Based on the high efficacy of interleukin‐1(IL‐1)‐inhibition in cold‐induced urticarial autoinf...

Full description

Bibliographic Details
Main Authors: Hanna Bonnekoh, Monique Butze, Sebastian Spittler, Petra Staubach, Karsten Weller, Jörg Scheffel, Marcus Maurer, Karoline Krause
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Clinical and Translational Allergy
Subjects:
autoinflammation
cold urticaria
dermatology
immunology
interleukin‐1
rilonacept
Online Access:https://doi.org/10.1002/clt2.12226

Internet

https://doi.org/10.1002/clt2.12226

Similar Items